Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Nov 10, 2022 10:47am
120 Views
Post# 35088377

RE:Derisked?

RE:Derisked?Keep an eye on the big picture. Are you buying the company for the base business alone, discounting that every PGX initiative will be a flop?

When Gilles says the company is de-risked, he means the base business (growing at 10% annually) through it's cash flow and profits has been able to support the cost of R&D without equity raises and diluting the share price or going bankrupt if unable to raise funds.

For now, modest revenue growth comes from the commodity type base business sales of AV and BG in its current form. Real breakthrough revenue growth comes from the large markets that PGX technology could be used for. 


Alex1726 wrote: Not at all , all sales comes from ONE customer. J&J so do not tell me there is no risk.


<< Previous
Bullboard Posts
Next >>